Trial Profile
Curing HCV in Incarcerated Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2019
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms CHIP
- 30 May 2017 Planned End Date changed from 1 May 2018 to 4 Jun 2018.
- 30 May 2017 Planned primary completion date changed from 1 Feb 2018 to 4 Mar 2018.
- 30 May 2017 Status changed from not yet recruiting to recruiting.